Early Career Mycoplasma and Chlamydia Researcher Conference 2022


Welcome!

The ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) invite you to attend the first conference for Early Career Mycoplasma and Chlamydia Researchers – ECMCR 2022. 

The conference will place virtually on Tuesday 18th October 2022

 

Focus of the conference

This conference has been designed to give early career researchers an opportunity to present their research in a low-pressure and welcoming environment and build on their presentation skills. It will also serve to highlight career development opportunities in this field.  Finally, we have two invited speakers who will give an overview of their career paths and provide insight on making the most out of your research career.

 

We welcome abstract submission on all aspects of mycoplasma and chlamydia biology with relation to human health and disease. This may encompass clinical presentation, epidemiology, development and mechanisms of antimicrobial resistance in relation to Mycoplasma, Ureaplasma and Chlamydia infections in humans as well advances in diagnosis, treatment, control and prevention.

 

Who can attend?

This conference is aimed at early career researchers (ECRs). 

 

We do not want to restrict attendance to this conference, but as a guide we have loosely defined ECRs as undergraduate or postgraduate students, technicians, post-doctoral researchers, or newly appointed academic/physicians within their first five years of appointment.  There may be specific individual situations, which do not fall within this definition, therefore we are flexible on whether you see yourself as an ECR.

 

Registration


Register now here

To promote participation from early career researchers, registration for this conference is FREE.

 

Although not mandatory, we encourage delegates to sign up to the ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) - ESCMID members can sign up for free here

 

Prizes will be awarded to the best oral and poster presentations. To be considered for theses prizes you MUST be a member of ESGMAC at the time of abstract submission. See Prizes section for more details.  

 

Abstracts


This year, ECMCR will be accepting late breaking abstract submissions from September 1 to September 22, 2022. This is an additional opportunity to present your most pressing research results that were previously not available or not ready at the time of the first abstract submission. The abstract structure should follow the same format, and acceptance/non-acceptance of the late-breaking abstracts will be announced by the end of September by e-mail.

 

Abstracts are to be submitted using a structured format and should not exceed 350 words for the sections Background, Methods, Results and Conclusion.

 

Please use the ECMCR abstract submission form (here) to structure your abstract.

 

Abstracts selected for poster presentation will be compiled into a digital poster booklet and distributed to delegates alongside summaries of oral presentations.

 

Please send your abstracts to: ECMCR2022[at]outlook.com

 

Programme Overview


  1. Introduction and welcome to the meeting
  2. Invited guest speaker – Dr Vicki Chalker – Chief Scientific Officer, National Health Service Blood and Transplant
  3. Session 1: Accepted oral abstracts
  4. Comfort break and online poster viewing
  5. Session 2: Accepted oral abstracts
  6. Lunch break and online poster viewing
  7. Invited guest speaker – Dr. Sunčanica Ljubin-Sternak - Full Professor at the University of Zagreb School of Medicine
  8. Session 3: Accepted oral abstracts
  9. Joint discussion on the Mycoplasma and Chlamydia Delphi Study
  10. Awarding of prizes and closing of the meeting

Guest Speakers


Victoria Chalker

Chief Scientific Officer, National Health Service Blood and Transplant

Dr. Chalker worked on Mycoplasma and Chlamydia species for 22 years. She started her career on Mollicutes in dogs, cats, tortoises and animals with the Royal Veterinary College. The former head of the UK national reference unit with remit for human mollicutes and chlamydia species, introducing services in respiratory chlamydia, mollicutes in neonates and Mycoplasmapneumoniae. She developed the sexually transmitted reference services to include Mycoplasmagenitalium. She Chairs the International Committee on Systematics of Prokaryotes (ICSP) Subcommittee on the Taxonomy of Mollicutes and has led global studies and established ESGMI – the Mycoplasma study group that contributed to the formation of ESCMAC.

 

Dr. Sunčanica Ljubin-Sternak

Full Professor at the University of Zagreb School of Medicine

Dr. Sunčanica Ljubin-Sternak is a Medical Doctor, Clinical Microbiology Specialist/Consultant and a Head of the Molecular Microbiology Department at the Teaching Institute for Public Health Dr. Andrija Štampar in Zagreb, Croatia. She is also a Full Professor at the Department of Medical Microbiology of the University of Zagreb School of Medicine, where she coordinates and leads a postgraduate study programme in clinical microbiology. She is actively involved in the research of Chlamydia and Mycoplasma epidemiology and susceptibility patterns, and she has successfully mentored several PhD candidates and clinical microbiology trainees. She is a member of many scientific societies and an avid lecturer.

Prizes


We are pleased to announce prizes will be awarded to the top oral and poster presentations.

 

These will be a cash prize in addition to reimbursement of two years ESCMID membership fees at the Young Scientist membership value (Euro 80).

 

To be considered for theses prizes you MUST be a member of ESGMAC at the time of abstract submission.

 

Sponsors